These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2129350)

  • 1. Effect of treatment with enalapril, verapamil and indomethacin on compensatory renal growth in the rat.
    Wight JP; Bassett AH; Le Carpentier JE; el Nahas AM
    Nephrol Dial Transplant; 1990; 5(9):777-80. PubMed ID: 2129350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of verapamil treatment on compensatory renal growth in mice.
    Broulík PD
    Physiol Res; 1998; 47(5):347-50. PubMed ID: 10052603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of compensatory renal growth by indomethacin.
    Logan JL; Lee SM; Benson B; Michael UF
    Prostaglandins; 1986 Feb; 31(2):253-61. PubMed ID: 3457404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy or streptozotocin-induced diabetes in the rat.
    Jackson B; Cubela R; Debrevi L; Whitty M; Johnston CI
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S167-9. PubMed ID: 2455124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic nephropathy in the rat: differing renal effects of an angiotensin converting enzyme inhibitor and a calcium inhibitor.
    Whitty MR; Jackson B
    Diabetes Res; 1988 Jun; 8(2):91-6. PubMed ID: 2852570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term enalapril and verapamil in rats with reduced renal mass.
    Brunner FP; Thiel G; Hermle M; Bock HA; Mihatsch MJ
    Kidney Int; 1989 Dec; 36(6):969-77. PubMed ID: 2557483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic nephrectomy with chronic angiotensin converting enzyme inhibitor treatment in renovascular hypertension in the rat.
    Jackson B; Franze L; Sumithran E; Johnston CI
    J Lab Clin Med; 1990 Jan; 115(1):21-7. PubMed ID: 2299253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further studies on the effects of cyclooxygenase inhibitors on compensatory renal growth.
    Logan JL; Benson B
    Prostaglandins Leukot Med; 1987 Nov; 30(1):9-15. PubMed ID: 3124137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enalapril in subantihypertensive dosage attenuates kidney proliferation and functional recovery in normotensive ablation nephropathy of the rat.
    Krivosíková Z; Sebeková K; Spustová V; Lajdová I; Dzúrik R
    Physiol Res; 1999; 48(6):429-35. PubMed ID: 10783907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
    Ciechanowicz A
    Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertrophic response of the kidney in indomethacin treated rats.
    Vasadi P; Selmeci L; Pósch E; Hársing L
    Acta Physiol Acad Sci Hung; 1979; 53(4):427-32. PubMed ID: 94742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclophosphamide and inhibition of renal compensatory hypertrophy.
    Araujo CG; Trindade JC; Bastos HD; Lautenschlager MF
    Braz J Med Biol Res; 1985; 18(4):533-9. PubMed ID: 2425875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal haemodynamics and function in weanling rats treated with enalapril from birth.
    Guron G
    Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):865-70. PubMed ID: 16173949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of indomethacin on the renal response to angiotensin II receptor blockade in healthy subjects.
    Fricker AF; Nussberger J; Meilenbrock S; Brunner HR; Burnier M
    Kidney Int; 1998 Dec; 54(6):2089-97. PubMed ID: 9853274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal function and urinary prostanoid excretions in salt-depleted women: comparative effects of enalapril and indomethacin treatments.
    Agnoli GC; Borgatti R; Cacciari M; Lenzi P; Marinelli M; Stipo L
    Prostaglandins Leukot Essent Fatty Acids; 1999 Feb; 60(2):87-93. PubMed ID: 10328327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compensatory renal growth: interactions of nephrectomy serum and urine antisera leading to a new theory of renal growth regulation.
    Snow BW; Tarry WF; Duckett JW
    Urol Res; 1987; 15(1):1-4. PubMed ID: 3824709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibition decreases growth factor expression in the neonatal rat kidney.
    Yoo KH; Wolstenholme JT; Chevalier RL
    Pediatr Res; 1997 Nov; 42(5):588-92. PubMed ID: 9357928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of captopril and enalapril on the progression of chronic renal disease in partially nephrectomized rats.
    Fettman MJ; Wilke WL; VanHouten DS; Hamar DW; Mikita DJ
    Res Commun Chem Pathol Pharmacol; 1989 Aug; 65(2):131-46. PubMed ID: 2555851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiency.
    Mackie FE; Meyer TW; Campbell DJ
    Kidney Int; 2002 Feb; 61(2):555-63. PubMed ID: 11849396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat.
    Szabo A; Lutz J; Schleimer K; Antus B; Hamar P; Philipp T; Heemann U
    Kidney Int; 2000 Mar; 57(3):982-91. PubMed ID: 10720951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.